Research progress in contrast-enhanced ultrasound for pancreatic diseases

doi:10.3877/cma.j.issn.2095-3232.2026.01.019

Abstract

Abstract:

In recent years, contrast-enhanced ultrasound (CEUS) acts as an ultrasound examination technique widely applied in the diagnosis and treatment of vital organ diseases such as pancreas, liver and kidney, providing clinicians with more detailed and comprehensive information to guide subsequent diagnosis and treatment. CEUS is applied in pancreatic diseases, mainly including pancreatitis, pancreatic tumor, pancreatic biopsy and interventional therapy, etc. In this article, research progress in the application of CEUS for pancreatic diseases was reviewed.

Key words: Contrast-enhanced ultrasound, Pancreatic diseases, Pancreatic needle biopsy, Interventional therapy, Sonazoid

Peng Li, Weizhen Zhang, Guoshuai Wu, Yifan Ma, Lingqiang Zhang. Research progress in contrast-enhanced ultrasound for pancreatic diseases[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(01): 119-123.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3232.2026.01.019

https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/Y2026/V15/I01/119

References 43

[1]	Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(7): 493-502. DOI: 10.1038/s41575-021-00457-x.
[2]	Dietrich CF, Averkiou M, Nielsen MB, et al. How to perform contrast-enhanced ultrasound (CEUS)[J]. Ultrasound Int Open, 2018, 4(1): E2-E15. DOI: 10.1055/s-0043-123931.
[3]	Zhang Q, Liang X, Zhang Y, et al. A review of contrast-enhanced ultrasound using SonoVue^® and Sonazoid™ in non-hepatic organs[J]. Eur J Radiol, 2023, 167: 111060. DOI: 10.1016/j.ejrad.2023.111060.
[4]	D'Onofrio M, Zamboni G, Faccioli N, et al. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging[J]. Abdom Imaging, 2007, 32(2): 171-181. DOI: 10.1007/s00261-006-9010-6.
[5]	Golea A, Badea R, Socaciu M, et al. Quantitative analysis of tissue perfusion using contrast-enhanced transabdominal ultrasound (CEUS) in the evaluation of the severity of acute pancreatitis[J]. Med Ultrason, 2010, 12(3): 198-204.
[6]	Wolske KM, Ponnatapura J, Kolokythas O, et al. Chronic pancreatitis or pancreatic tumor? A problem-solving approach[J]. Radiographics, 2019, 39(7): 1965-1982. DOI: 10.1148/rg.2019190011.
[7]	Liu J, Hu L, Zhou B, et al. Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis[J]. Transl Oncol, 2022, 18: 101357. DOI: 10.1016/j.tranon.2022.101357.
[8]	欧阳向柳, 韩云霞, 郑立春, 等. 肿块型自身免疫性胰腺炎与胰腺导管腺癌的超声及超声造影表现分析[J]. 临床肝胆病杂志, 2022, 38(6): 1351-1355. DOI: 10.3969/j.issn.1001-5256.2022.06.025.
[9]	Yang J, Huang J, Zhang Y, et al. Contrast-enhanced ultrasound and contrast-enhanced computed tomography for differentiating mass-forming pancreatitis from pancreatic ductal adenocarcinoma: a meta-analysis[J]. Chin Med J, 2023, 136(17): 2028-2036. DOI: 10.1097/CM9.0000000000002300.
[10]	中国医师协会胰腺病学专业委员会, 国家消化系统疾病临床医学研究中心(上海). 中国胰腺实性肿瘤影像学诊断报告规范循证学指南[J]. 中华胰腺病志, 2024, 24(2): 100-113. DOI: 10.3760/cma.j.cn115667-20240227-00046.
[11]	Wang Y, Li G, Yan K, et al. Clinical value of contrast-enhanced ultrasound enhancement patterns for differentiating solid pancreatic lesions[J]. Eur Radiol, 2022, 32(3): 2060-2069. DOI: 10.1007/s00330-021-08243-8.
[12]	Mukund A, Afridi MA, Karolak A, et al. Pancreatic ductal adenocarcinoma (PDAC): a review of recent advancements enabled by artificial intelligence[J]. Cancers, 2024, 16(12): 2240. DOI: 10.3390/cancers16122240.
[13]	Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention[J]. Gastroenterology, 2023, 164(5): 752-765. DOI: 10.1053/j.gastro.2023.02.012.
[14]	Jia WY, Gui Y, Chen XQ, et al. Evaluation of the diagnostic performance of the EFSUMB CEUS Pancreatic Applications guidelines (2017 version): a retrospective single-center analysis of 455 solid pancreatic masses[J]. Eur Radiol, 2022, 32(12): 8485-8496. DOI: 10.1007/s00330-022-08879-0.
[15]	Perik T, Alves N, Hermans JJ, et al. Automated quantitative analysis of CT perfusion to classify vascular phenotypes of pancreatic ductal adenocarcinoma[J]. Cancers, 2024, 16(3): 577. DOI: 10.3390/cancers16030577.
[16]	Zhou T, Tan L, Gui Y, et al. Correlation between enhancement patterns on transabdominal ultrasound and survival for pancreatic ductal adenocarcinoma[J]. Cancer Manag Res, 2021, 13: 6823-6832. DOI: 10.2147/ CMAR.S 307079.
[17]	贾婉莹, 桂阳, 陈雪琪, 等. 超声造影评估胰腺导管腺癌血供模式[J]. 中国医学影像技术, 2024, 40(12): 1861-1866. DOI: 10.13929/j.issn.1003-3289.2024.12.012.
[18]	Mohindroo C, McAllister F, De Jesus-Acosta A. Genetics of pancreatic neuroendocrine tumors[J]. Hematol Oncol Clin North Am, 2022, 36(5): 1033-1051. DOI: 10.1016/j.hoc.2022.07.005.
[19]	Dong Y, Yang DH, Tian XF, et al. Pancreatic neuroendocrine tumor: prediction of tumor grades by radiomics models based on ultrasound images[J]. Br J Radiol, 2023, 96(1149): 20220783. DOI: 10.1259/bjr.20220783.
[20]	Yang D, Wang D, Qiu Y, et al. Incidental nonfunctioning pancreatic neuroendocrine tumors: contrast enhanced ultrasound features in diagnosis1[J]. Clin Hemorheol Microcirc, 2022, 80(4): 343-352. DOI: 10.3233/ch-211269.
[21]	Jia WY, Gui Y, Chen XQ, et al. Pancreatic ductal adenocarcinoma with synchronous and metachronous hepatic metastasis predicted by contrast-enhanced ultrasound[J]. Quant Imaging Med Surg, 2023, 13(6): 3902-3914. DOI: 10.21037/qims-22-1132.
[22]	Al Efishat M, Allen PJ. Therapeutic approach to cystic neoplasms of the pancreas[J]. Surg Oncol Clin N Am, 2016, 25(2): 351-361. DOI: 10.1016/j.soc.2015.11.006.
[23]	Yuan Z, Li J, Yang L, et al. The differential diagnosis of pancreatic cystic neoplasms with conventional ultrasound and contrast-enhanced ultrasound[J]. Quant Imaging Med Surg, 2024, 14(7): 4304-4318. DOI: 10.21037/qims-24-154.
[24]	院志强, 李加伍, 时莹瑜, 等. 常规超声及超声造影在胰腺囊肿和囊性肿瘤鉴别诊断中的研究[J]. 中国超声医学杂志, 2024, 40(9): 1031-1033.
[25]	桂阳, 吕珂, 梁华, 等. 859例胰腺占位性病变超声造影诊断的准确性分析[J]. 协和医学杂志, 2024, 15(4): 825-830. DOI: 10.12290/xhyxzz.2024-0204.
[26]	曾兰, 任思谦, 李飞, 等. 超声造影及其联合血清学指标评估胰腺癌可切除性[J]. 中国医学影像技术, 2023, 39(8): 1210-1214. DOI: 10.13929/j.issn.1003-3289.2023.08.020.
[27]	Crinó SF, Brandolese A, Vieceli F, et al. Endoscopic ultrasound features associated with malignancy and aggressiveness of nonhypovascular solid pancreatic lesions: results from a prospective observational study[J]. Ultraschall Med, 2021, 42(2): 167-177. DOI: 10.1055/a-1014-2766.
[28]	Rimbaş M, Crino SF, Gasbarrini A, et al. EUS-guided fine-needle tissue acquisition for solid pancreatic lesions: Finally moving from fine-needle aspiration to fine-needle biopsy?[J]. Endosc Ultrasound, 2018, 7(3): 137-140. DOI: 10.4103/eus.eus_23_18.
[29]	Facciorusso A, Cotsoglou C, Chierici A, et al. Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration versus standard fine-needle aspiration in pancreatic masses: a propensity score analysis[J]. Diagnostics, 2020, 10(10): 792. DOI: 10.3390/diagnostics10100792.
[30]	Otsuka Y, Kamata K, Kudo M. Contrast-enhanced harmonic endoscopic ultrasound-guided puncture for the patients with pancreatic masses[J]. Diagnostics, 2023, 13(6): 1039. DOI: 10.3390/diagnostics13061039.
[31]	Seicean A, Jinga M. Harmonic contrast-enhanced endoscopic ultrasound fine-needle aspiration: fact or fiction?[J]. Endosc Ultrasound, 2017, 6(1): 31-36. DOI: 10.4103/2303-9027.196917.
[32]	Gincul R, Palazzo M, Pujol B, et al. Contrast-harmonic endoscopic ultrasound for the diagnosis of pancreatic adenocarcinoma: a prospective multicenter trial[J]. Endoscopy, 2014, 46(5): 373-379. DOI: 10.1055/s-0034-1364969.
[33]	王晓庆, 梁轩, 李德毅, 等. 超声造影联合超声引导细针穿刺对胰腺恶性肿瘤的诊断价值[J]. 中国肿瘤临床, 2024, 51(9): 480-481. DOI: 10.12354/j.issn.1000-8179.2024.20240522.
[34]	中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中华外科杂志, 2021, 59(7): 578-587. DOI: 10.3760/cma.j.cn112139-20210416-00172.
[35]	Song Y, Lee SH. Recent treatment strategies for acute pancreatitis[J]. J Clin Med, 2024, 13(4): 978. DOI: 10.3390/jcm13040978.
[36]	Huang DY, Yusuf GT, Daneshi M, et al. Contrast-enhanced ultrasound (CEUS) in abdominal intervention[J]. Abdom Radiol, 2018, 43(4): 960-976. DOI: 10.1007/s00261-018-1473-8.
[37]	牛佳美, 汪佳旭, 熊家伟, 等. 超声造影在急性胰腺炎诊疗中的应用进展[J/OL]. 中华医学超声杂志(电子版), 2019, 16(3): 173-175. DOI: 10.3877/cma.j.issn.1672-6448.2019.03.003.
[38]	Catalano O, Lobianco R, Cusati B, et al. Contrast-enhanced sonography for diagnosis of ruptured abdominal aortic aneurysm[J]. AJR Am J Roentgenol, 2005, 184(2): 423-427. DOI: 10.2214/ajr.184.2.01840423.
[39]	Maruyama H, Sekimoto T, Yokosuka O. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience[J]. J Gastroenterol, 2016, 51(5): 421-433. DOI: 10.1007/s00535-015-1151-3.
[40]	Makino Y, Imai Y, Fukuda K, et al. Sonazoid-enhanced ultrasonography for the diagnosis of an intrapancreatic accessory spleen: a case report[J]. J Clin Ultrasound, 2011, 39(6): 344-347. DOI: 10.1002/jcu.20798.
[41]	Tatekawa Y. An intrapancreatic accessory spleen presenting as a rapidly growing pancreatic mass after splenectomy in a patient with hereditary spherocytosis: a case report and literature review[J]. J Surg Case Rep, 2018, 2018(2): rjy029. DOI: 10.1093/jscr/rjy029.
[42]	Park S, Je H, Jang S, et al. Comparison of sulfur hexafluoride microbubbles and perfluorobutane for performance of contrast-enhanced ultrasonography of the pancreas in dogs[J]. Am J Vet Res, 2021, 82(7): 538-545. DOI: 10.2460/ajvr.82.7.538.
[43]	Schultz CW, Ruiz de Garibay G, Langer A, et al. Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical model[J]. Cancer Biol Ther, 2021, 22(3): 204-215. DOI: 10.1080/15384047.2021.1881026.

Please choose a citation manager

Content to export